Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by an educational grant/educational grants from Foundation Medicine, Inc.

Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer Care

Release Date: November 30, 2017
Expiration Date: November 30, 2018
Media: Internet - based


Activity Overview

This online activity, which includes expert opinions from 2 faculty members, discusses the optimization of diagnosis, treatment selection, and management of patients with cancer using emerging tumor-testing technologies. It covers such exciting topics as liquid biopsies, next-generation sequencing, and tumor mutation burden. This activity also explores what tumor-testing technologies are expected in the future and which technologies can be used to improve the care of patients with cancer right now.

Acknowledgement of Commercial Support

This activity is supported by an educational grant/educational grants from Foundation Medicine, Inc.

CME/CE Activity Table of Contents

  • Module 1. Advantages and Challenges of Next-Generation Sequencing
  • Module 2. Gaining Familiarity With Plasma (Liquid) Biopsies
  • Module 3. Evolving Use of Tumor Mutation Burden
  • Module 4. Looking Forward With Tumor-Testing Technologies

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a cme/ce certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a cme/ce certificate upon completion of these steps.

Target Audience

This educational program is primarily directed toward medical oncologists who treat patients with cancer. It has been developed to meet the needs of the “everyday oncologist” in community practice. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the treatment of cancer will also be invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Analyze strategies for tumor testing in patients with cancer, including next-generation sequencing, liquid biopsies, comprehensive genomic profiling, hotspot analysis, and tissue biopsies
  • Implement best practices to individualize treatment of patients with cancer based on assessment of the tumor profile and patient characteristics
  • Explain the role of multidisciplinary teams in facilitation and implementation of novel tumor-testing technologies in clinical practice settings
  • Integrate office-based systems and guideline use to overcome barriers to personalized medicine and increase cancer screening in the community setting

Faculty, Staff, and Planners' Disclosures


Joseph A. Sparano, MD
Professor, Department of Medicine (Oncology)
Professor, Department of Obstetrics & Gynecology and Women’s Health
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Disclosure: Grant/Research Support - Prescient, Deciphera; Consultant - Eli Lilly, Pfizer, Genentech, AstraZeneca; Stock/Shareholder - MetaStat, Inc.

Balazs Halmos, MD
Professor of Clinical Medicine
Section Chief Thoracic Oncology
Director, Clinical Cancer Genomics
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Disclosure: Grant/Research Support - Merck, Astra-Zeneca/Medimmune. Pfizer. Novartis, Eli-Lilly. Mirati. Boehringer-lngelheim, BMS. Takeda. Consultant: Foundation One. Guardant Health. Genoptix. Eli-Lilly. Pfizer, Celgene. Astra-Zeneca. Boehringer-lngelheim. Novartis. Takeda

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Become a Member

Forgot Password?
Calendar of Events
Filter By